Liposomal interleukin-2: Began Phase II testing

Biomira Inc. (BIOM; TSE:BRA), Edmonton, Alberta
Product: Liposomal interleukin-2
Business: Cancer
Therapeutic

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE